F-18 FDG–Positron Emission Tomographic Scanning and Wegener’s Granulomatosis
- 1 October 2002
- journal article
- case report
- Published by Ovid Technologies (Wolters Kluwer Health) in Clinical Nuclear Medicine
- Vol. 27 (10), 705-706
- https://doi.org/10.1097/00003072-200210000-00004
Abstract
Wegener's granulomatosis is a necrotizing granulomatous vasculitis that mainly affects the upper airways, lungs, and kidneys. Autoimmune mechanisms are hypothesized to play a role in the pathophysiology of the disease. F-18 fluorodeoxyglucose-positron emission tomographic scanning is normally used to differentiate benign from malignant disease as a result of differences in glucose metabolism. The authors present a case of Wegener's granulomatosis in which F-18 fluorodeoxyglucose-positron emission tomographic scanning yielded a false-positive result.Keywords
This publication has 6 references indexed in Scilit:
- Validation of FDG positron emission tomography for differentiation of unknown pulmonary lesions.European Journal of Cardio-Thoracic Surgery, 2001
- F-18 Fluorodeoxyglucose Chest Uptake in Lung Inflammation and InfectionClinical Nuclear Medicine, 2000
- Rare diseases bullet 3: Wegener's granulomatosisThorax, 1999
- Fluorine-18 deoxyglucose and false-positive results: a major problem in the diagnostics of oncological patientsEuropean Journal of Nuclear Medicine and Molecular Imaging, 1996
- Wegener's Granulomatosis in North IndiaActa Radiologica, 1988
- On the Origin of Cancer CellsScience, 1956